Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: COVID-19, Interchange of vaccine products, SARS-CoV-2 test
Clinical narrative: Interchange of vaccine products; Was vaccinated for COVID-19 and then tested positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Was vaccinated for COVID-19 and then tested positive) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication and REMDESIVIR for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form, first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form On an unknown date, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. and REMDESIVIR (unknown route) at an unspecified dose. On 19-May-2022, the patient experienced COVID-19 (Was vaccinated for COVID-19 and then tested positive). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). At the time of the report, COVID-19 (Was vaccinated for COVID-19 and then tested positive) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-May-2022, SARS-CoV-2 test: positive (Positive) Positive.         Concomitant medication was not provided. Patient was prescribed with Paxlovid as antiviral treatment but caller said that he has not taken the drug Paxlovid yet.  Company comment.  This spontaneous case concerns a 66yearold male patient with no medical history reported, who experienced the unexpected, non  serious AESI of COVID  19, after a booster dose of mRNA-1273 vaccine; third dose of his COVID  19 immunization schedules; the patient previously had two doses of Pfizer COVID  19 vaccines (interchange of vaccine products.). Temporal association cannot be assessed due to lack of information on vaccination date. The report stated that the patient tested positive for COVID  19 and he wanted to get some antivirals. No further details were provided for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report; Sender's Comments: This spontaneous case concerns a 66  year  old male patient with no medical history reported, who experienced the unexpected, non  serious AESI of COVID  19, after a booster dose of mRNA-1273 vaccine; third dose of his COVID  19 immunization schedules; the patient previously had two doses of Pfizer COVID  19 vaccines (interchange of vaccine products.). Temporal association cannot be assessed due to lack of information on vaccination date. The report stated that the patient tested positive for COVID  19 and he wanted to get some antivirals. No further details were provided for medical review. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.